Clinical Oncology (Medical Treatment, Radiotherapy) and Precision Medicine

All Items

• Understanding quality of life in Danish women with metastatic breast cancer undergoing multiple treatments

  Helle Pappot, Annasofie Jørgensen, Anna Hincheli Bjørum, Christina Bøgh Jakobsen, Camilla Uhre Jørgensen, Beverley Lim Høeg, Pernille Bidstrup, Ann Knop, Line Bentsen

  292-302

• Fine needle aspiration cytology including the analysis of human papilloma virus (HPV) DNA enhances the diagnostic workup of solitary cystic neck lesions in a population with a high incidence of HPV positive oropharyngeal cancer

  Evelina Jörtsö, Linda Marklund, Martin Harper Hysek, Anders Näsman, Lalle Hammarstedt-Nordenvall, Mathias von Beckerath, Tina Dalianis, Rusana Bark

  276-283

• Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy

  Rutger H. Stoffers, Anne G.H. Niezink, Olga Chouvalova, Jan F. Ubbels, Marleen Woltman-van Iersel, T. Jeroen N. Hiltermann, Lucie B.M. Hijmering-Kappelle, Gea Douma, Sander M. de Hosson, John W.G. van Putten, Friso T. Zandberg, Lisanne V. van Dijk, Johannes A. Langendijk, Robin Wijsman

  267-275

• Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

  Pia J. Heino, Jukka Pappinen, John F. Thompson, Micaela Hernberg, Tiina A. Jahkola, Mark B. Faries

  247-256

• Infantile undifferentiated sarcomas: a diagnostic and therapeutic challenge – two case reports and literature review

  Aleksandra Stanio, Jakub Czarny, Sandra Rutkowska, Katarzyna Adamczewska-Wawrzynowicz, Łukasz Młynarczyk, Agnieszka Stróżyk, Katarzyna Jończyk-Potoczna, Alicja Bartkowska-Śniatkowska, Jacek Wachowiak, Katarzyna Derwich, Olga Zając-Spychała

  241-246

• Determining the effect of frailty on survival in advanced ovarian cancer: study protocol for a prospective multicentre national cohort study (FOLERO)

  Daniel Hunde, Niklas Ekerstad, Mihaela Asp, Päivi Kannisto, Madelene Wedin, Charlotte Palmqvist, Pernilla Dahm-Kähler, Yvonne Brandberg, Mirna Abraham-Nordling, Kristina Åhlund, Vilhelm Mörlin, Nina Groes-Kofoed, Sahar Salehi

  208-213

• Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study

  Niklas B. Lindahl, Jakob Lauritsen, Thomas Wagner, Gedske Daugaard, Mikkel Bandak

  191-199

• Real-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study

  Antti Rannikko, Olivia Hölsä, Trude Ågesen, Mattias Ekman, Riikka Mattila

  173-178

• Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data

  Bogdana Patachi, Kristian H. Jensen, Anita Gothelf, Mogens Bernsdorf, Jeppe Friborg, Claus A. Kristensen

  143-146

• Knowledge and understanding of information after taking decision to participate or not in a randomized trial of surgery vs radiotherapy among patients with locally advanced prostate cancer – an observational study

  Yvonne Brandberg, Olof Akre, Mia Bergenmar

  167-172

• Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials

  Syrine Ben Dhia, Damien Chauviere, Diana Mitrea, Renaud Schiappa, Tanguy Pace Loscos , Emmanuel Chamorey , David Baron

  120-128

• Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma – a retrospective single-centre analysis

  Anton Burkhard-Meier, Vera Valerie Rechenauer, Luc M. Berclaz, Vindi Jurinovic, Markus Albertsmeier, Hans Roland Dürr, Sinan E. Güler, Michael Hoberger, Alexander Klein, Thomas Knösel, Wolfgang G. Kunz, Nina-Sophie Schmidt-Hegemann, Michael von Bergwelt-Baildon, Lars H. Lindner, Dorit Di Gioia

  56-62

• Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions

  Eivind Storaas, Marta D. Switlyk, Sigrun Dahl, Cecilie D. Amdal , Åse Bratland, Thuy-Tien M. Huynh, Hanne A. Eide, Barbara Vischioni, Ester Orlandi, Einar Dale

  63-68

• Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma

  Bauke H.G. van Riet, Milan van Meekeren, Marta Fiocco, Aisha Miah, Ilse de Pree, Lisette M. Wiltink, Astrid Scholten, Lotte Heimans, Judith V.M.G. Bovée, Hans Gelderblom, Neeltje Steeghs, Rick L. Haas

  69-77

• Coasting related to taxane-induced peripheral neuropathy in patients with breast cancer: a systematic review

  Freja L. Kruse, Margrethe B. Bille, Maria E. Lendorf, Susan Vaabengaard, Steffen Birk

  78-86

• Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

  Hege S. Haugnes, Hakon Kjaeve, Eivind Bjerkaas, Ragnhild Hellesnes, Line Hjelle, Magnus Larsen

  13-21

• The clinical utility of circulating human papillomavirus across squamous cell carcinomas

  Karen-Lise G. Spindler, Anne V. Jakobsen, Jesper G. Eriksen, Lars Fokdal, Marianne Nordsmark, Lise B. J. Thorsen, Karen L. Wind, Anna C. Lefevre, Jens Overgaard

  1-12

• From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway

  Denise Reis Costa, Anna K. Winge-Main, Anna Skog, Kaitlyn M. Tsuruda, Trude Eid Robsahm, Bettina Kulle Andreassen

  965-973

• Imaging-based evaluation of cervical muscle mass and 6-month survival in males with hypopharyngeal carcinoma

  Jouni Laurén, Harri Keski-Säntti, Antti Mäkitie, Otso Arponen

  950-957

• Clinico-pathological characteristics and treatment outcome in non-small cell lung cancer in Greenland 2015–2020 – a comparison with the cohort from 2004 to 2010

  Dorte S. Nørøxe, Simone Frandsen, Malene M. Clausen, Thomas I. Hansen, Uka W. Geisler, Alice J. Petersen, Seppo W. Langer

  958-964

• ESHO 2–85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology

  Jens Overgaard, Olav Dahl, Giorgio Arcangeli

  943-949

• Denosumab combined with radiotherapy as an alternative to surgery for advanced metastatic bone lesions and pathologic fractures: a retrospective case study of 38 patients

  Mehdy Farhang, Martin Isaksson, Johan Wänman, Richard Löfvenberg, Sead Crnalic

  932-938

• Adherence to adjuvant endocrine therapy after breast cancer in Sweden – a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences

  Anna De Jong, Anna Von Wachenfeldt, Lennarth Nyström, Anne Andersson

  901-908

• NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial

  Jean-Matthieu L'Orphelin, Ugo Lancien , Jean-Michel Nguyen , Francisco J.S. Coronilla, Soraya Saiagh , Julie Cassecuel , Lise Boussemart, Anne Dompmartin , Brigitte Dréno

  867-877

• The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy

  Cem Onal, Ozan Cem Guler, Aysenur Elmali, Birhan Demirhan, Melek Yavuz

  858-866